GSK 1702934A
924377-85-5
|
GSK-114 2HCl
1301760-19-9
|
GSK-J5
1394854-51-3
|
GSK-1016790A
942206-85-1
|
GSK 635416A
944729-29-7
|
GSK-J1
1373422-53-7
|
GSK 583
1346547-00-9
|
GSK-3β inhibitor 2
1702428-31-6
|
GSK 264220A
685506-42-7
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
6-Bromo-3-iodo-1-methyl-1H-pyrrolo[3,2-c]pyridine
2748542-15-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
